Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
Adrenergic sympathomimetic agent used in the treatment of orthostatic hypotension and cardiovascular syncope.
Oral or intravenous administration.
Since the last update we have not found any published data on its excretion in breast milk.
Its short half-life make transfer into breastmilk in significant quantities unlikely.
Its low oral bioavailability would make it difficult its passage to the infant’s plasma through breast milk except in premature babies and in the immediate neonatal period during which there may be greater intestinal permeability.
Trendelemburg position, may produce the same clinical improvement as (empiric) ethylephrine or propranolol therapy (Di Girolamo 1998).
There are very few bibiographical references and it is marketed in few countries.